United States Federal Circuit

In a patent dispute concerning a prostate cancer drug, defendant's product does not infringe upon plaintiff's patents, either literally or under the doctrine of equivalents, and summary judgment of noninfringement in its favor is affirmed.

Appellate Information

• Decided 08/18/2005
• Published 08/18/2005

Judges

• BRYSON, Circuit Judge., Before NEWMAN, BRYSON, and GAJARSA, Circuit Judges.

Court

• United States Federal Circuit

Counsel

• For Appellees:
  
• William F. Cavanaugh, Jr., Patterson, Belknap, Webb & Tyler LLP, of New York, New York argued for plaintiffs/counterclaim defendants-cross appellants and plaintiff-appellee.   With him on the brief was Stuart E. Pollack.   Of counsel on the brief were Henry J. Renk and Bruce M. Wexler, Fitzpatrick, Cella, Harper & Scinto, of New York, New York., Thomas H. Shunk, Baker & Hostetler LLP, of Cleveland, Ohio, argued for defendants/counterclaimants-appellants.   With him on the brief was Kyle B. Fleming.   Of counsel on the brief was Richard A. Sharpe, Pearne & Gordon, L.L.P., of Cleveland, Ohio.